# SONATA

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sonata

- Industry: Healthcare
- Headquarters: New York, US
- Website: www.sonata.health
- Total disclosed funding: $7M
- Latest round: Seed (Jul 14, 2026)
- Investors on record: 3

## About

SONATA is a US-based healthcare company that prioritizes proactive disease prevention through personalized medical care, offering innovative services such as in-home blood draws and clinical-grade testing for health-conscious individuals and families. Founded in 2025 and Sagan Schultz is the cofounder and CEO of SONATA. SONATA specializes in personalized healthcare services. The company raised USD 7.00 mn in its latest funding round on July 14, 2026, from investors including Lux Capital, BoxGroup, and Sunflower Capital. The total amount raised to date is USD 7.00 mn, with only one deal reported thus far.SONATA provides a comprehensive concierge healthcare membership focused on proactive disease prevention through personalized medical care. This includes in-home blood draws and clinical-grade testing, such as whole genome sequencing and analysis, covering over 140 blood biomarkers. The service is tailored for health-conscious individuals and families seeking preventive care to manage their health effectively.SONATA generates revenue via an annual subscription model, allowing members to access personalized healthcare services. Clients pay an annual fee of USD 2,500, which includes unlimited consultations with board-certified physicians and extensive genomic and biomarker testing. This model fosters long-term relationships with members, emphasizing preventive healthcare.Following the recent funding round in July 2026, SONATA plans to utilize the USD 7.00 mn raised to enhance its product offerings and expand into new urban markets across the United States. The company is strategizing the introduction of additional preventive care services and aims to target specific demographics with tailored solutions to meet their health needs.


The company will use the July 2026 funding to expand its clinical AI platform, grow digital care networks, and support member onboarding in New York, San Francisco, and Los Angeles.

## Funding rounds

- Seed, Jul 14, 2026, $7M — Lux Capital, BoxGroup, Sunflower Capital

## Investors

- Lux Capital (https://capitalatlas.ai/funds/lux-capital) — Seed
- BoxGroup (https://capitalatlas.ai/funds/boxgroup) — Seed
- Sunflower Capital (https://capitalatlas.ai/funds/sunflower-capital) — Seed